In this exclusive PC Podcast interview, Dave DeJean, Systech’s VP of global strategic accounts, dives into:
- The valuable lessons he’s learned along the way, given his three and half decades of experience at Systech
- An overview of the Drug Supply Chain Security Act (DSCSA), including its three main pillars
- How he would interpret this “Stabilization Period” that the FDA provided this past summer, and what he pharma industry do now during this period in order to avoid penalties later
- Whether or not he anticipates the FDA implementing any other sort of delays in the near future in order to help remedy these issues/challenges surrounding the enactment of DSCSA
